After receiving the ethical approval in Tanzania, NeuroSolve obtained the ethical clearance in Zambia too. The ethical clearance certificate will allow to conduct medical research on Neurocysticercosis also in Zambia.

NeuroSolve is a four-year project funded by the European Commission and EDCTP3, started on May 1, 2023. The African Institutions involved are: University of Dar es Salaam (Tanzania), Sokoine University of Agriculture (Tanzania), University of Zambia (Zambia); the European Institutions are: Universiteit Ghent (Belgium) and R-Evolution Worldwide Srl – Impresa Sociale (Italy), that is also the project Coordinator. NeuroSolve is committed to fight taeniasis/Neurocysticercosis (NCC) disease in Sub-Saharan Africa.

Potrebbe essere un'immagine raffigurante testo

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

50th anniversary of the WHO declaration of malaria-free Italy

On the 50th anniversary of the WHO declaration of malaria-free Italy, national and international institutions engaged in the fight against malaria meet to discuss the contribution of scientific research to

Read More

Second International Conference on Public Health in Africa

  The Second International Conference on Public Health in Africa (CPHIA) was held in Kigali on 13th-15th December 2022. In CPHIA 2022 conference were addressed discussion on need to ensure global health

Read More

R-Evolution Worldwide is glad to announce the launch of a collaboration with the University of Salento, (the local University, in southern Italy) and with the University of Sciences, Techniques and

Read More